KLE University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT02409680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

KLE University's Jawaharlal Nehru Medical College | KLE University's J N Medical College

Active Ingredients

Drugs in Other Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Death (Phase 3)

Infections (Phase 3)

Maternal Death (Phase 3)

Neonatal Sepsis (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1